Patients with congenital heart disease (CHD) with right ventricle outflow tract (RVOT) dysfunction need sequential pulmonary valve replacements throughout their life in the majority of cases. Since their introduction in 2000, the number of percutaneous pulmonary valve implantations (PPVI) has grown and reached over 10,000 procedures worldwide. Overall, PPVI has been proven safe and effective, but some anatomical variations can limit procedural success. This review discusses the current status and future perspectives of the procedure
SummarySince the first transcatheter implantation of a pulmonary valve in 2000 in a twelve year-old ...
Introduction: Percutaneous pulmonary valve implantation (PPVI) initiated a new era in the interventi...
AbstractObjectivesWe report our experience of percutaneous valve insertion in pulmonary position in ...
AbstractDue to recurrent right ventricular outflow tract (RVOT) dysfunction, patients with complex c...
Patients with congenital or acquired heart defects affecting the pulmonary valve and right ventricul...
Background—Right ventricular outflow tract (RVOT) reconstruction with valved conduits in infancy and...
Percutaneous pulmonary valve implantation (PPVI) is now an accepted alternative option to convention...
SummaryPercutaneous pulmonary valve implantation now has a key role in the setting of dysfunctional ...
IntroductionPatient selection for percutaneous pulmonary valve insertion PPVI is widely accepted, be...
OBJECTIVES: The aim of the study was to assess indications, procedural success, complications, echoc...
PurposeRight ventricular outflow tract (RVOT) reconstruction in infancy or childhood leads to lifeti...
Percutaneous pulmonary valve implantation (PPVI) is one of the most exciting recent developments in ...
AIMS Multiple surgical revisions are often necessary in individuals with congenital heart defects a...
ObjectivesThe aim of this study was to investigate physiological and clinical consequences of percut...
Adult survivors with congenital heart disease are not cured and residual cardiac valve lesions are c...
SummarySince the first transcatheter implantation of a pulmonary valve in 2000 in a twelve year-old ...
Introduction: Percutaneous pulmonary valve implantation (PPVI) initiated a new era in the interventi...
AbstractObjectivesWe report our experience of percutaneous valve insertion in pulmonary position in ...
AbstractDue to recurrent right ventricular outflow tract (RVOT) dysfunction, patients with complex c...
Patients with congenital or acquired heart defects affecting the pulmonary valve and right ventricul...
Background—Right ventricular outflow tract (RVOT) reconstruction with valved conduits in infancy and...
Percutaneous pulmonary valve implantation (PPVI) is now an accepted alternative option to convention...
SummaryPercutaneous pulmonary valve implantation now has a key role in the setting of dysfunctional ...
IntroductionPatient selection for percutaneous pulmonary valve insertion PPVI is widely accepted, be...
OBJECTIVES: The aim of the study was to assess indications, procedural success, complications, echoc...
PurposeRight ventricular outflow tract (RVOT) reconstruction in infancy or childhood leads to lifeti...
Percutaneous pulmonary valve implantation (PPVI) is one of the most exciting recent developments in ...
AIMS Multiple surgical revisions are often necessary in individuals with congenital heart defects a...
ObjectivesThe aim of this study was to investigate physiological and clinical consequences of percut...
Adult survivors with congenital heart disease are not cured and residual cardiac valve lesions are c...
SummarySince the first transcatheter implantation of a pulmonary valve in 2000 in a twelve year-old ...
Introduction: Percutaneous pulmonary valve implantation (PPVI) initiated a new era in the interventi...
AbstractObjectivesWe report our experience of percutaneous valve insertion in pulmonary position in ...